Objectives: To evaluate the surgical feasibility of laparoscopic adrenalectomy using the lateral retroperitoneal approach for the treatment of large pheochromocytomas, and to identify the preoperative risk factors for intraoperative hypertension. Methods: We retrospectively reviewed 51 patients who underwent laparoscopic adrenalectomy using the lateral retroperitoneal approach for the treatment of pheochromocytomas. Patient characteristics and perioperative outcomes were analyzed and compared between the two study groups based on tumor size: group A (n = 27, ≤6 cm) and group B (n = 24, ˃6 cm). Results: There was no significant difference in preoperative characteristics between the two groups except for tumor size (P = 0.001) and urinary metanephrine (P = 0.011). Group B patients required longer operating time (P = 0.008), had a greater estimated blood loss (P = 0.001) and hemoglobin change (P = 0.002). However, no significant differences were observed in perioperative complications and mortality. Multivariate analysis showed that symptomatic pheochromocytomas (P = 0.004) and tumor size (P = 0.007) were significant risk factors for intraoperative hypertension. Conclusions: Laparoscopic adrenalectomy using the lateral retroperitoneal approach for pheochromocytomas can be regarded as a treatment option, even for tumors measuring >6 cm. Symptomatic pheochromocytomas and large tumor size seem to represent risk factors for intraoperative hypertension.
Introduction PCC, a rare tumor (incidence of 0.1-0.6% in hypertensives) arising from chromaffin cells of the adrenal medulla or extra-adrenal paraganglia, usually presents with symptoms attributable to hormonal secretion, or could be a mass incidentally detected on imaging studies.
1,2 Despite a variable presentation, unregulated excessive catecholamine secretion can cause myocardial infarction, cerebrovascular accidents, acute renal failure and acute respiratory distress syndrome. 1 Surgical resection is the only definitive treatment for PCC. Since it was first introduced by Gagner et al., 3 this minimally invasive LA approach has now become the gold standard for surgical removal of benign lesions of the adrenal glands. 4 Despite improvements in surgical techniques and perioperative management, LA for PCC is a challenging procedure because of the risk of intraoperative hemodynamic instability. 5 Recently, several reports have shown the safety and effectiveness of LA for PCC, but the indications for using the laparoscopic approach for large tumors remain debatable, 6 and most laparoscopic procedures are carried out using the transperitoneal and/or posterior retroperitoneal approach. 7, 8 The aim of the present study, carried out at a single hospital, was to evaluate the surgical feasibility of LA using the lateral retroperitoneal approach for PCCs larger than 6 cm without extra-adrenal extension, and to identify the preoperative risk factors for intraoperative hypertension.
Methods Patients
We retrospectively evaluated the records of 51 patients who underwent retroperitoneal LA for PCC at Chonnam National University Hwasun Hospital, Hwasun, Korea, between September 2005 and March 2016. All laparoscopic procedures were carried out or supervised by an experienced laparoscopic surgeon, and we carried out LA for PCC using the lateral retroperitoneal approach regardless of tumor size. Patients were assessed with respect to demographic and tumor characteristics, such as age, sex, BMI, ASA score, circumstances of tumor detection, underlying disease, tumor laterality, tumor size, previous history of hypertension, duration of use of antihypertensive medication, and levels of preoperative urinary catecholamines and metabolites.
Preoperative evaluation and perioperative care
Preoperative evaluation including the patient's clinical presentation, and assessment of biochemical and radiological parameters, was used to diagnose PCC. Biochemical evaluation included laboratory tests for endocrine function including epinephrine, norepinephrine, metanephrine and VMA levels in a 24-h urine sample. Patients underwent computed tomography and/or magnetic resonance imaging, and metaiodobenzylguanidine scintigraphy was carried out to confirm the presence of extra-adrenal extension.
All patients diagnosed with PCC were administered an antihypertensive drug regardless of the previous history of hypertension and its associated symptoms (headache, sweating, palpitations and dizziness among others). Administration of alpha blockers (doxazosin) was initiated at least 2 weeks before the operation. A subgroup of patients was administered beta-blockers to control blood pressure and/or heart rate after alpha-blockade. Adequate pre-treatment was defined as a target blood pressure of 130/85 mmHg. 9 All patients received general anesthesia and underwent a close monitoring of the central venous pressure. Heart rate, SBP and DBP were monitored continuously before beginning the operation. The number of episodes with SBP >180 mmHg and MAP <60 mmHg were measured to monitor intraoperative blood pressure fluctuation, and were used as a cut-off value for intraoperative hypertension and hypotension. MAP was calculated using the formula:
Operative procedure
All patients underwent LA using the lateral retroperitoneal approach as previously described. 10 Briefly, we used a fourtrocar technique, as shown in Figure 1 . After placement of the trocar, we opened the Gerota's fascia and mobilized the upper pole of the kidney to expose the adrenal gland. We ligated the adrenal vein early in the procedure and reduced manipulation of the adrenal mass to avoid the risk of excessive catecholamine secretion and tumor disruption. 11 During the right adrenalectomy, the inferomedial surface of the adrenal gland was dissected off the renal vein and the inferior vena cava along with the dissection of the lateral and superior surfaces. During the left adrenalectomy, dissection and caudal retraction of the left renal artery helped in identifying the adrenal vein. The superior surface of the adrenal gland was dissected with ligation of the inferior phrenic vessels. The lateral surface was dissected off the kidney, followed by dissection of the inferomedial surface with cephalad retraction. The adrenal gland, regardless of its size, was placed in a bag and removed through the 12-mm trocar site. The drain tube was inserted into the 5-mm port in the anterior axillary line.
Statistical analysis
Perioperative and postoperative outcomes were analyzed and compared between the two groups. Variables considered were intraoperative hemodynamic parameters, operating time, estimated blood loss, perioperative changes in hemoglobin, return to diet, time until drain removal, postoperative hospital stay and rate of conversion to an open procedure. The severity of postoperative complications was evaluated based on the Clavien-Dindo classification.
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Continuous variables were compared using independent Student's t-tests and the Mann-Whitney U-test, and categorical variables were compared using v 2 -tests. Multiple linear regression analysis was carried out to determine the independent predictor of prolonged operation time and greater blood loss. Univariate and multivariate logistic regression analysis were carried out to determine the preoperative risk factors for intraoperative hypertension. All data were analyzed using SPSS, version 23.0 (SPSS, Chicago, IL, USA). Differences were considered statistically significant at a value of P < 0.05.
Results
We studied 51 patients who underwent LA using the lateral retroperitoneal approach for PCC. All patients included in our study had been diagnosed with PCC confirmed by histopathological evaluation.
Demographic data and preoperative characteristics for all patients are summarized in Table 1 . Patients' mean age was 52 years, and 26 (51%) of them were women with a mean BMI of 23.3 kg/m 2 . The majority of patients were classified based on the ASA score as I or II (n = 41, 80.3%). In 26 (51%) patients, the tumor was detected based on observation of symptoms attributable to hormone secretion, and 27 (52.9%) patients were previously diagnosed as having hypertension. Furthermore, 29 (56.9%) tumors affected the left adrenal gland, and the mean tumor size was 5.6 cm.
Patients were divided into two groups based on tumor size: group A (n = 27, tumor ≤6 cm) and group B (n = 24, tumor ˃6 cm). There was no significant difference in preoperative patient characteristics between the two groups except in tumor size (3.9 AE 0.9 cm vs 7.4 AE 1.1 cm; P = 0.001). On analyzing intraoperative and postoperative outcomes, group B patients had a longer operating time (172.0 AE 59.8 min vs 221.3 AE 67.1 min; P = 0.008), greater estimated blood loss (161.9 AE 78.6 mL vs 297.1 AE 102.7 mL; P = 0.001) and change in hemoglobin (1.7 AE 0.8 g/dL vs 2.6 AE 1.2 g/dL; P = 0.002). Multiple linear regression analysis showed that the tumor size is an independent predictor of prolonged operation time and greater blood loss (both P = 0.001). Intraoperative hypertension was observed in 25 (49.0%) patients, and was more frequently noted in group B than in group A patients (29.6% vs 70.8%; P = 0.003). One patient with tumor size 8.5 cm belonging to group B needed to undergo an open surgery because of intraoperative bleeding during dissection of the right adrenal vein. Group B patients showed a higher incidence of postoperative complications including the need for a blood transfusion. All five patients with a grade II complication received a blood transfusion during their hospital stay. However, there was no major complication (Clavien-Dindo ≥3) in both groups, and statistically non-significant differences were observed in terms of postoperative complications and mortality (Table 2) .
Preoperative risk factors for intraoperative hypertension during the procedure are detailed in Table 3 . Univariate analysis showed that detection of tumor based on symptoms attributable to hormonal secretion and tumor size was associated with a higher risk of intraoperative hypertension. Additionally, using multivariate analysis, these two factors (OR 16.85, 95% CI 2.46-115.552, P = 0.004; OR 1.081, 95% CI 1.02-1.14, P = 0.007) could be considered independent risk factors for intraoperative hypertension. We observed intraoperative hypotension in 20 (39.2%) patients with no significant differences between the two groups. These episodes were not severe, and were successfully managed with intravenous injection and fluid administration by anesthesiologists.
Malignant PCC was observed in one patient in group B. During annual postoperative follow up, 4 years after the LA for a large-sized PCC (8.2 cm), the patient showed recurrence of a large (7.9 cm) mass and several small masses in the mesentery of the small bowel anterior to the left kidney. The en bloc resection of the masses was carried out as a cooperative effort along with general surgeons, and the patient is now on follow up. Discussion PCC is a rare tumor, for which surgical management is the only treatment option. Determining a safe and feasible surgical approach for the adrenalectomy, and recognizing possible intra-and perioperative difficulties is paramount for surgeons. The present study showed that LA using the lateral retroperitoneal approach for PCC would be a good treatment option regardless of tumor size with appropriate perioperative hemodynamic control. The present results favor the application of this procedure in clinical practice, because the incidence of intraoperative hypertension is higher in patients who are symptomatic at presentation and/or in those with a large tumor size.
Although LA has now become the gold standard for the surgical removal of benign lesions of the adrenal gland, 4 several studies have reported that increasing tumor size could result in greater operative difficulties with a higher rate of complications and the need to convert the procedure into an open procedure. 13 Large tumor size increases the risk of malignancy, which in turn increases the possibility of tumor dissemination and port site recurrence.
14 In LA for PCC, hemodynamic instability resulting from pneumoperitoneum, tumor manipulation and the difficulty in removing highly vascular tumors increases surgical difficulties. 15 Large tumors require increased tumor manipulation during dissection and resection, thereby causing greater release of hormones and ensuing hemodynamic fluctuation. 16 Recent studies have reported that LA carried out for PCC by surgeons with vast experience in laparoscopic procedures and rapid developments in judicious anesthetic management have contributed to a very low mortality and morbidity. 17 Kercher et al. 18 have reported longer operating times and Toniato et al. 17 have shown greater blood loss associated with larger tumors than smaller ones during laparoscopic surgery. However, these authors have concluded that tumor size does not influence surgical outcomes. In a prospective study of 163 PCC patients, it was shown that LA can be carried out safely and successfully for tumors >6 cm without suspicion of malignancy with results comparable with treatment of smaller tumors. 6 Similarly, in the present study, the group showing a large tumor size had longer operating time and greater estimated blood loss with more significant change in hemoglobin levels compared with those belonging to the small-sized tumor group. However, there was no significant difference with respect to surgical complications and intraoperative and postoperative outcomes between both groups. Among all adrenal tumors, PCC removal has a greater likelihood of requiring conversion to an open procedure during LA. 19 We needed to convert our LA to an open procedure in one patient belonging to the large tumor group as a result of intraoperative bleeding. A report concluded that surgical experience along with a good team effort has a major role in determining operative results and complications in all surgical procedures. 20 In the present study, all laparoscopic procedures were carried out or supervised by an expert laparoscopic surgeon and an experienced surgical team. Thus, we noted positive intraoperative and postoperative outcomes with a low rate of significant complications and morbidity.
We can conclude from our experience, as shown by a recent systemic review, 21 that LA using the retroperitoneal approach was superior or at least comparable with the transperitoneal approach in terms of operative feasibility and postoperative complications. LA using the retroperitoneal approach also has its disadvantages, such as difficult anatomical orientation, smaller working space and the possibility of closer proximity of the port sites. 21 The direct approach to the adrenal gland and vein, avoiding the need to enter the peritoneal cavity or mobilizing adjacent organs, as well as avoiding adhesions from previous surgery are the primary advantages of a retroperitoneoscopic adrenalectomy. 22 Additionally, it effectively minimizes postoperative blood loss because of the small space of the retroperitoneum. 10 Early adrenal vein ligation before tumor manipulation is beneficial in patients with PCC to reduce the risk of excessive catecholamine secretion and cardiovascular complications. 11, 23 Based on the present results, the large tumor group showed a longer operating time and greater quantities of blood loss with significant changes in hemoglobin levels compared with those belonging to the small tumor group. However, it should be noted that most of the patients in the large tumor group (75%) underwent the operation in the first half of the enrollment period. Considering the nature of the learning curves, our operative outcome reflects an improvement in surgical techniques.
Since Walz et al. 24 first described LA using the posterior retroperitoneal approach, several studies have shown distinct advantages of this approach when compared with a conventional LA. 7, 8, 21 However, a comparison between LA using the lateral retroperitoneal approach and other surgical approaches has rarely been reported. 10, 25 Although the anatomical orientation of the retroperitoneoscopic technique might be more difficult using a lateral rather than posterior approach, it could result in shorter operating time with favorable outcomes when carried out by experienced surgeons after a certain learning curve. 25 When retroperitoneoscopic adrenalectomy is carried out for PCC, patients with a posterior approach seemed to have a greater incidence of intraoperative risks than those with a lateral approach, owing to the following reasons: (i) the patient's position on the operative table itself could directly cause hemodynamic instability; 26 (ii) it is not easy to rapidly convert the procedure into an open technique in the case of major bleeding; 27 and (iii) in patients with a high BMI, the adipose tissue raises intra-abdominal pressure in the dorsal position, and the retroperitoneal space is highly compressed because of the presence of excess adipose tissue. 25 The presentation of PCC is variable. In the present study, patients presenting with symptoms attributable to excessive hormonal secretion mostly belonged to the large tumor group compared with the small tumor group (66.7% vs 40.7%). These patients and the large tumor size acted as independent predictive risk factors for intraoperative hypertension. The association between large tumor size and hemodynamic fluctuation is well known based on the previous studies, as well as our own. 16, 28 The present findings show that high quantities of hormones are released during surgery in symptomatic patients, resulting in hemodynamic fluctuation, than in those with an incidental PCC. Prevention and management of intraoperative hemodynamic instability is a major concern for surgeons and anesthesiologists while operating on patients with PCC. With adequate medical pre-treatment, perioperative mortality rates have dropped to <3%, which highlights the importance of proper preoperative management. 16 Several studies have shown that high levels of urinary catecholamines or metabolites were associated with poor perioperative outcomes and hemodynamic instability. 16, 29 As shown in previous studies, tumor size directly correlates with hormone levels, and the present results corroborated the fact that higher levels of urinary catecholamines and metabolites are associated with larger tumors compared with smaller ones. 28 However, no significant correlation was detected between hormone levels and intraoperative hypertension. These results are similar to a study reported by Tauzin-Fin et al. showing that pre-treatment with an alpha-blocker effectively maintains a stable intraoperative hemodynamic status; 30 however, a significant correlation between hypertensive events and hormonal levels was not detected. Interestingly, the present results show that intraoperative hypertension tends to occur more commonly during a right adrenalectomy, which could be associated with the shorter right adrenal vein and increased possibility of tumor manipulation.
In the present study, we noted one patient with a malignant PCC, a large-sized tumor and intraoperative hypertension. Although a large PCC is usually associated with a high rate of malignancy, no clear association was reported with tumor size. 17 There was no difference in perioperative hemodynamic instability in patients with benign versus malignant PCCs. 15 In malignant tumors, radical surgical removal is the mainstay of treatment with annual follow up for at least 10 years. 1, 14 The present study had several limitations: (i) it was a retrospective study with a relatively small sample size, carried out in a single hospital without comparison with another surgical approach; (ii) although the surgeries in our hospital were carried out by an experienced surgeon and his team, our results include perioperative data obtained from those who could have been less experienced; and (iii) we analyzed the risk factors for intraoperative hypertension defined as SBP >180 mmHg, which could be managed safely by an anesthesiologist; therefore, the results of the present study cannot be generalized and applied to other surgeons, and possible risk factors for intraoperative hypertension might not be completely applicable to all patients with PCC; and (iv) the length of hospital stay in this study was relatively longer than other LA studies. This could have affected not only the surgical outcome, but also the patient's preferences. In Korea, patients tend to have long hospital stays because of low hospital stay cost by the regulation of the National Health Insurance Corporation. However, the present study is important because it focuses on a unique lateral retroperitoneal approach for PCC given the lack of previous research in LA.
In conclusion, LA using the lateral retroperitoneal approach could be an alternative treatment of choice with proper perioperative hemodynamic control in the surgical treatment of patients with PCC, regardless of tumor size. In our study, tumor detection based on symptoms attributable to hormonal secretion (symptomatic PCC) and large tumor size was independently associated with intraoperative hypertension.
